FIELD: electricity.
SUBSTANCE: invention relates to semiconductor devices comprising a matrix of hold-up cells in which each hold-up cell is configured to contain a medicament and each hold-up cell comprises a cell activation element configured to release the medicament from the hold-up cell upon obtaining an activation trigger.
EFFECT: device improvement.
18 cl, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD AND OPHTHALMIC DEVICE WITH ACTIVE AGENT RELEASE SYSTEM | 2015 |
|
RU2677538C2 |
| METHODS AND DEVICE FOR MANUFACTURING OF OPHTHALMIC DEVICES COMPRISING PHOTONIC ELEMENTS | 2014 |
|
RU2651058C2 |
| OPHTHALMIC DEVICES INCORPORATING PHOTONIC ELEMENTS | 2014 |
|
RU2650578C2 |
| INTERMITTENT DRUG FEED FROM LACHRYMAL OPENING PLUG | 2010 |
|
RU2539556C2 |
| IMPLANTS OF NASOLACRIMAL DRAINAGE SYSTEM FOR DRUG THERAPY | 2007 |
|
RU2414199C2 |
| TEAR DUCT PLUGS | 2010 |
|
RU2530723C2 |
| OPHTHALMIC DEVICES WITH ORGANIC SEMICONDUCTOR TRANSISTORS | 2014 |
|
RU2650089C2 |
| METHODS OF DRUG DELIVERY, LACHRYMONASAL SYSTEM STRUCTURES AND COMPOSITIONS | 2007 |
|
RU2413480C2 |
| METHOD AND OPHTHALMIC DEVICE FOR ENSURING VISUAL REPRESENTATIONS FOR THE USER | 2014 |
|
RU2648221C2 |
| QUANTUM-DOT SPECTROMETERS FOR USE IN BIOMEDICAL DEVICES AND METHODS OF USE | 2016 |
|
RU2665202C2 |
Authors
Dates
2017-09-11—Published
2013-02-27—Filed